Mahad et al., showed that the in vitro model of blood-brain barrier (BBB) was selectively permeable for migrating CCR2+ lymphocytes and monocytes, and suggest the pathological importance of infiltrated CCR2 expressing PBMCs in multiple sclerosis (MS) [22]. Here, CCR2 is linked to myeloid sarcoma.